HOST DETERMINANTS OF ORGANIC DUST INDUCED AIRWAY DISEASE

有机粉尘诱发气道疾病的宿主决定因素

基本信息

  • 批准号:
    6343653
  • 负责人:
  • 金额:
    $ 25.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-02-10 至 2002-12-31
  • 项目状态:
    已结题

项目摘要

The goals of this proposal are to determine whether the airway response to inhaled endotoxin is a genetically based trait in humans and to assess to what extent the expression of this trait is influenced by gender. Occupational and environmental exposure to grain dust can cause asthma and bronchitis. Endotoxin appears to be one of the primary components of grain dust (and other organic dusts) that causes airway inflammation and airflow obstruction. Lipopolysaccharide (LPS) is a specific type of endotoxin found in the cell wall of gram-negative bacteria. In a murine model, we have confirmed that LPS resistance is determined by a single gene (Lps response gene), and we have localized this gene to a 220,000 base pair region on chromosome 4. In preliminary human studies, we have shown that most health, non-asthmatic, non-apoptotic, life-timer non-cigarette smoking volunteers develop airflow obstruction with challenged with increasing concentrations of inhaled LPS. However, approximately 10% of subjects developed marked airflow obstruction after inhaling trivial amounts of LPS and 15% of subjects appear to be hyporesponsive after inhaling over 40 micrograms of LPS. In addition, females demonstrate greater bronchial sensitivity to inhaled LPS than males. These results lead us to hypothesize that the airway response to inhaled LPS is a genetically determined complex trait in humans. Moreover, gender appears to substantially influence the airway response to inhaled LPS. We will use a familial cohort design to determine whether the airway response to inhaled endotoxin is a genetically based trait in humans, and to assess to what extent the expression of this trait is influence by gender. The study design is dependent on two interactive stages. In the first stage, we will screen a relatively large population of healthy, unrelated volunteers (n=200) with incremental doses of inhaled LPS. This will allow us to identify approximately 50 study subjects who will serve as "sensitive" or "hyporesponsive" probands. These sensitive and hyporesponsive probands will be used to identify families for the second stage of this investigation. In the second stage of the study, we will evaluate the airway response to incremental doses of inhaled LPS among 100 first degree relatives of up to 50 sensitive and hyporesponsive probands. Finds from this study will help us to determine why only a small portion of workers develop airway disease when exposed to organic dust.
本提案的目标是确定气道对 吸入的内毒素是人类的一种遗传特征, 这种特质的表达在多大程度上受到性别的影响。 谷物粉尘的职业和环境暴露可引起哮喘, 支气管炎内毒素似乎是谷物的主要成分之一 粉尘(和其他有机粉尘),导致气道炎症和气流 梗阻脂多糖(LPS)是一种特殊类型的内毒素 存在于革兰氏阴性菌的细胞壁中。在小鼠模型中,我们 已经证实LPS抗性是由单个基因(LPS)决定的, 反应基因),我们已经将该基因定位到220,000个碱基对 4号染色体上的区域。在初步的人类研究中,我们已经表明, 最健康、无哮喘、无细胞凋亡、终生不吸烟 吸烟志愿者发展气流阻塞, 增加吸入LPS的浓度。然而,大约10%的 受试者在吸入少量 大量的LPS和15%的受试者出现低反应后, 吸入了超过40微克的脂多糖此外,女性表现出 支气管对吸入LPS的敏感性高于男性。这些结果 使我们假设气道对吸入性脂多糖的反应是一种 由基因决定的复杂特征此外,性别似乎 从而显著影响气道对吸入LPS的反应。我们将使用 一个家族性队列设计,以确定是否气道反应, 吸入的内毒素是人类的一种遗传特征, 性别对这一特征的表达有多大的影响。研究 设计取决于两个交互阶段。在第一阶段,我们将 筛选一个相对较大的健康、无关的志愿者群体 (n=200)增加吸入LPS剂量。这将使我们能够 确定大约50名研究受试者,他们将作为“敏感”或 “反应迟钝”先证者这些敏感和低反应的先证者 将用于确定家庭的第二阶段, 调查在研究的第二阶段,我们会评估 100个一级患者对递增剂量吸入LPS的气道反应 多达50个敏感和低反应先证者的亲属。调查结果来自 这项研究将帮助我们确定为什么只有一小部分工人 暴露在有机粉尘中会导致呼吸道疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David A Schwartz其他文献

Identification of pathologic features associated with ╜ulcerative colitis-like╚ Crohn╎s disease
鉴定与“溃疡性结肠炎样”克罗恩病相关的病理特征
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Samuel D James;Paul E Wise;Tania Zuluaga;David A Schwartz;M. Kay;Chanjuan Shi
  • 通讯作者:
    Chanjuan Shi
Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients
家族性肺纤维化患者亲属的临床前间质性肺疾病
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sionne EM Lucas;Kelsie Raspin;J. Mackintosh;I. Glaspole;P. Reynolds;Collin Chia;Christopher Grainge;Peter Kendall;Lauren Troy;David A Schwartz;R. Wood;S. Walsh;Y. Moodley;James Robertson;Sacha;Macansh;E. Walters;Daniel C. Chambers;T. Corte;L. Joanne;Dickinson
  • 通讯作者:
    Dickinson
Thrombolytic therapy of massive pulmonary embolism during prolonged cardiac arrest using recombinant tissue-type plasminogen activator
  • DOI:
    10.1016/s0196-0644(89)80527-x
  • 发表时间:
    1989-06-01
  • 期刊:
  • 影响因子:
  • 作者:
    Robert W Langdon;William R Swicegood;David A Schwartz
  • 通讯作者:
    David A Schwartz

David A Schwartz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David A Schwartz', 18)}}的其他基金

THE GENETICS OF ENVIRONMENTAL ASTHMA
环境性哮喘的遗传学
  • 批准号:
    7198457
  • 财政年份:
    2005
  • 资助金额:
    $ 25.47万
  • 项目类别:
ROLE OF RHUMAB-E25 IN DECREASING EXHALED NO IN PATIENTS WITH ALLERGIC ASTHMA
RHUMB-E25 在减少过敏性哮喘患者呼出气体中的作用
  • 批准号:
    7198471
  • 财政年份:
    2005
  • 资助金额:
    $ 25.47万
  • 项目类别:
The Genetics of Environmental Asthma
环境性哮喘的遗传学
  • 批准号:
    6974021
  • 财政年份:
    2004
  • 资助金额:
    $ 25.47万
  • 项目类别:
RhuMAB-E25 in Decreasing Exhaled NO in Patients w/Asthma
RhuMAB-E25 减少哮喘患者呼出一氧化氮
  • 批准号:
    6974039
  • 财政年份:
    2004
  • 资助金额:
    $ 25.47万
  • 项目类别:
A Linkage Study in Familial Pulmonary Fibrosis
家族性肺纤维化的关联研究
  • 批准号:
    6974015
  • 财政年份:
    2004
  • 资助金额:
    $ 25.47万
  • 项目类别:
Center for Comparative Biology of Vulnerable Populations
弱势群体比较生物学中心
  • 批准号:
    6704015
  • 财政年份:
    2004
  • 资助金额:
    $ 25.47万
  • 项目类别:
The Pathogenesis and Genetics of Environmental Asthma
环境性哮喘的发病机制和遗传学
  • 批准号:
    6677838
  • 财政年份:
    2003
  • 资助金额:
    $ 25.47万
  • 项目类别:
CENTER FOR ENVIRONMENATL GENOMICS
环境基因组学中心
  • 批准号:
    6655584
  • 财政年份:
    2001
  • 资助金额:
    $ 25.47万
  • 项目类别:
CENTER FOR ENVIRONMENTAL GENOMICS
环境基因组学中心
  • 批准号:
    6438972
  • 财政年份:
    2001
  • 资助金额:
    $ 25.47万
  • 项目类别:
MODEL TO STUDY THE ORIGIN OF PERSISTENT ENVIRONMENTAL AIRWAY DISEASE
研究持续性环境气道疾病起源的模型
  • 批准号:
    6564454
  • 财政年份:
    2001
  • 资助金额:
    $ 25.47万
  • 项目类别:

相似海外基金

Evaluation of Transmission Low-frequency Raman Spectroscopy for Application to Quality Assurance of Continuous Manufactured Solid Dosage Forms
透射低频拉曼光谱在连续生产固体剂型质量保证中的应用评价
  • 批准号:
    23K06071
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAREER: microRNA-mediated regulation of dosage sensitive genes involved in morphogenesis
职业:微小RNA介导的形态发生剂量敏感基因的调节
  • 批准号:
    2238425
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
    Continuing Grant
Use of Additives in Oral Solid Dosage Forms to Inhibit Nitrosamine Formation
在口服固体剂型中使用添加剂抑制亚硝胺形成
  • 批准号:
    2896874
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
    Studentship
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
一项 2 期、随机、双盲、4 组、多中心研究,旨在证明处方药局部剂量制剂治疗光化性角化病的有效性和安全性
  • 批准号:
    10820810
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
Estimation of optimal dosage of opioid based on vascular stiffness value
基于血管硬度值估算阿片类药物最佳剂量
  • 批准号:
    23K15598
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mapping and prediction of quantitative transcription factor dosage effects to understand variation in craniofacial morphology and disease
定量转录因子剂量效应的绘图和预测,以了解颅面形态和疾病的变化
  • 批准号:
    10641572
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
Creation of trait diversity through gene dosage effects in allopolyploid wheat
通过异源多倍体小麦基因剂量效应创造性状多样性
  • 批准号:
    22KJ1943
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Optimizing dosage and CTA-Enabling Pre-clinical Gene Therapy Studies for Creatine Transporter Deficiency
优化剂量和支持 CTA 的肌酸转运蛋白缺乏症临床前基因治疗研究
  • 批准号:
    491901
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
    Operating Grants
SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72
社会是小企业关注 NCGC72 的剂型开发、生产和稳定性研究
  • 批准号:
    10953952
  • 财政年份:
    2023
  • 资助金额:
    $ 25.47万
  • 项目类别:
Modulating Exercise Dosage to Improve Concussion Rehabilitation: A Randomized Clinical Trial
调节运动量以改善脑震荡康复:一项随机临床试验
  • 批准号:
    10412780
  • 财政年份:
    2022
  • 资助金额:
    $ 25.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了